---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-036513"
form_type: "8-K"
ticker: "CC"
cik: "0001627223"
company_name: "Chemours Co"
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T01:33:24.195759+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Chemours director Guillaume Pepy will not stand for re-election at 2025 annual meeting

## Summary
- Pepy notified the board on March 9, 2025 of his decision not to seek re-election.
- His current term will expire at the 2025 Annual Meeting of Shareholders.
- Pepy stated the decision is not due to any disagreement with company operations, policies, or practices.

## SEC filing metadata
- accession: 0000950170-25-036513
- form_type: 8-K
- ticker: CC
- cik: 0001627223
- company_name: Chemours Co
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1627223/000095017025036513/0000950170-25-036513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1627223/000095017025036513/cc-20250309.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-036513
- JSON: https://secwatch.observer/filing/0000950170-25-036513.json
- Plain text: https://secwatch.observer/filing/0000950170-25-036513.txt

## Key facts
- Executive change
  Guillaume Pepy departed as Director at Chemours Co.
  - Action: not seek re-election
  - Role: Director
  source text: On March 9, 2025, Guillaume Pepy notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of his decision not to seek re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, when his current term expires.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1627223/000095017025036513/0000950170-25-036513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.